EOJOAM
RVMD icon

E. Ohman J:or Asset Management’s Revolution Medicines RVMD Stock Holding History

E. Ohman J:or Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749K Hold
4,000
– – 0.02% 347
2026
Q1 		$389K Buy
+4,000
New +$404K 0.01% 434

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

E. Ohman J:or Asset Management's RVMD Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 4,000 shares worth $749K. The position accounts for 0.02% of the portfolio, ranked #347.

E. Ohman J:or Asset Management first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • E. Ohman J:or Asset Management held 4,000 shares of Revolution Medicines worth $749K as of Q2 2026.
  • E. Ohman J:or Asset Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 0.02% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #347 holding.
  • E. Ohman J:or Asset Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.